Why the Sigma Healthcare Share Price Fell Today

Shares of Sigma Healthcare Ltd [ASX:SIG] are down 28.52% today.

Why did the SIG share price fall?

Sigma has decided to pursue legal action against My Chemist/Chemist Warehouse Group. The dispute claimed by Sigma centres on a breach of supply agreement, with the two retailers intending to source products from a new wholesaler.

Sigma estimates the outcome could result in a $5 million dip in revenue.

This comes on the back of a slow earnings season for Sigma during the 2017/18 fiscal year. A 5% drop from the previous year.

The supply agreement between Sigma and pharmacy retailers runs until June 2019. Sigma has stated its commitment to the partnership.

What now for Sigma?

After changing their name from Sigma Pharmaceuticals earlier this year, Sigma seems to want to be involved in more than just wholesaling. Especially as they wait for findings from the Pharmacy Remuneration Review report. Sigma is hoping for an increase in revenue based on new remuneration models.

Legal costs and a tenuous relationship have not inspired investor confidence, though. Sigma and investors alike will wait to see how court proceedings progress.

Ryan Clarkson-Ledward,

For Money Morning

Ryan Clarkson-Ledward is an Editor at Money Morning.

Ryan holds degrees in both communication and international business. He helps bring Money Morning readers the latest market updates, both locally and abroad. Ryan tackles all the issues investors need to know about that the mainstream media neglects.

Ryan is also the Editor of Australian Small-Cap Investigator, a stock tipping newsletter that hunts down promising small-cap stocks by dissecting the latest events affecting the world.

To find out more about the publications Ryan works on and how you can subscribe, please click on the corresponding link here:

Money Morning Australia